Textbook of clinical trials: Difference between revisions

Jump to navigation Jump to search
(Redirected page to Category:Clinical trials)
 
(Removed redirect to Category:Clinical trials)
Tag: Removed redirect
Line 1: Line 1:
#redirect:[[Category:Clinical_trials]]
 
'''Ethical Issues'''
 
Helsinki agreement
 
Informed consent
 
Investigational Review Board (IRB)
 
HIPAA and patient privacy
 
 
 
'''Regulatory issues and pathways in clinical trials'''
 
1572
 
Investigational new drug (IND) application
 
Investigational new drug or device exemption
 
510K pathway
 
 
'''Designing Clinical Trials'''
 
Randomized controlled trials versus observational studies
 
Phase 1 trials
 
Pharmacokinetic (PK) and pharmcodynamic (PD) assessment
 
Phase 2 trials
 
Advancing from phase 2 to a phase 3 trial
 
Phase 3 trials
 
Parallel versus dose escalation studies
 
Hypothesis Generation
 
Inclusion and exclusion criteria
 
Stratification
 
Primary endpoint
 
Secondary endpoints and exploratory endpoints
 
Surrogate endpoints
 
Sample size and power calculations
 
Protocol creation
 
Abbreviations used in clinical trials
 
'''Operationalizing Clinical Trials'''
 
Principal investigator role
 
Executive committee role
 
Steering committee role
 
Nurse coordinator clinical research associate role
 
Monitor role
 
Sponsor role
 
Randomization service
 
Central laboratory facility
 
EKG core laboratory
 
Angiographic core laboratory
 
MRI core laboratory
 
Genetics core laboratory
 
Biomarker core laboratory
 
Identification of sites
 
Randomization
 
Blinding
 
Recruitment of study participants
 
Electronic data collection
 
Schedule of events
 
Concommittant medications
 
Clinical events committee
 
Adverse event, serious adverse event and serious unexpected events
Data safety monitoring board (DSMB)
 
Minimizing incomplete follow up of patients
 
Protocol adherence
 
Storage and handling of investigational product
 
Data management and designing an electronic data capture form
 
Source documents
 
Study completion and close out
 
Protocol amendments
 
Publication committee
 
'''Statistical Analysis of Clinical Trials'''
 
Cleaning a dataset
 
Summary statistics
 
Intent to treat versus modified intent to treat versus as treated
 
Student's t tests and analysis of variance
 
Chi square analysis and Fisher's exact test
 
Logistic regression
 
Multivariate modeling
 
Survival analysis
 
Handling missing data
 
Subgroup and interaction analyses
 
Net clinical benefit analyses
 
Cost effectiveness analyses
 
Quality adjusted life year analyses
 
Interim analyses and futility analyses
 
Reporting results and how to write a manuscript
 
Meta-analysis
 
Positive publication bias
 
"Study Tools"
 
GFR calculation

Revision as of 18:23, 24 October 2019

Ethical Issues

Helsinki agreement

Informed consent

Investigational Review Board (IRB)

HIPAA and patient privacy


Regulatory issues and pathways in clinical trials

1572

Investigational new drug (IND) application

Investigational new drug or device exemption

510K pathway


Designing Clinical Trials

Randomized controlled trials versus observational studies

Phase 1 trials

Pharmacokinetic (PK) and pharmcodynamic (PD) assessment

Phase 2 trials

Advancing from phase 2 to a phase 3 trial

Phase 3 trials

Parallel versus dose escalation studies

Hypothesis Generation

Inclusion and exclusion criteria

Stratification

Primary endpoint

Secondary endpoints and exploratory endpoints

Surrogate endpoints

Sample size and power calculations

Protocol creation

Abbreviations used in clinical trials

Operationalizing Clinical Trials

Principal investigator role

Executive committee role

Steering committee role

Nurse coordinator clinical research associate role

Monitor role

Sponsor role

Randomization service

Central laboratory facility

EKG core laboratory

Angiographic core laboratory

MRI core laboratory

Genetics core laboratory

Biomarker core laboratory

Identification of sites

Randomization

Blinding

Recruitment of study participants

Electronic data collection

Schedule of events

Concommittant medications

Clinical events committee

Adverse event, serious adverse event and serious unexpected events

Data safety monitoring board (DSMB)

Minimizing incomplete follow up of patients

Protocol adherence

Storage and handling of investigational product

Data management and designing an electronic data capture form

Source documents

Study completion and close out

Protocol amendments

Publication committee

Statistical Analysis of Clinical Trials

Cleaning a dataset

Summary statistics

Intent to treat versus modified intent to treat versus as treated

Student's t tests and analysis of variance

Chi square analysis and Fisher's exact test

Logistic regression

Multivariate modeling

Survival analysis

Handling missing data

Subgroup and interaction analyses

Net clinical benefit analyses

Cost effectiveness analyses

Quality adjusted life year analyses

Interim analyses and futility analyses

Reporting results and how to write a manuscript

Meta-analysis

Positive publication bias

"Study Tools"

GFR calculation